Option Care gets 75% of its revenues from chronic therapies and 25% from acute treatments, but its growth now looks ...

Jefferies analyst Brian Tanquilut upgraded the rating on Option Care Health (OPCH – Research Report) to a Buy today, setting a price target of ...

JMP Securities analyst Constantine Davides maintained a Buy rating on Option Care Health (OPCH – Research Report) today and set a price target ...

Fintel reports that on January 23, 2025, Jefferies upgraded their outlook for Option Care Health (NasdaqGS:OPCH) from Hold to Buy. Analyst Price Forecast Suggests 3.63% Upside As of December 23, 2024, ...

In this article, we are going to take a look at where Option Care Health (NASDAQ:OPCH) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Option Care Health (NASDAQ:OPCH) stands against the other ...

Better yet, you'd like to see the share price move up more than the market average. But Option Care Health, Inc. (NASDAQ:OPCH) has fallen short of that second goal, with a share price rise of 72% ...

Option Care Health Inc (OPCH) stock saw a modest uptick, ending the day at $30 which represents a slight increase of $0.69 or 2.35% from the prior close of $29.31. The stock opened at $30.43 and ...

Jefferies has upgraded Option Care Health (NASDAQ:OPCH) to buy from hold, citing removal of an overhang related to pricing adjustments for the drug Stelara. The investment bank said it had ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Option Care ...